The JAK inhibitor tofacitinib for active rheumatoid arthritis: results from Phase III trials

Author: Salgado Eva   Gómez-Reino Juan J  

Publisher: Future Medicine

ISSN: 1758-4272

Source: International Journal of Clinical Rheumatology, Vol.8, Iss.3, 2013-06, pp. : 315-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content